Bosh sahifaDMN • FRA
add
Diamyd Medical AB
Yopilish kursi
0,86 €
Kunlik diapazon
0,86 € - 0,86 €
Yillik diapazon
0,65 € - 1,62 €
Bozor kapitalizatsiyasi
1,32 mlrd SEK
Oʻrtacha hajm
47,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | avg, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 19,00 ming | 5,56% |
Joriy xarajat | 45,81 mln | 0,17% |
Sof foyda | -44,86 mln | 9,80% |
Sof foyda marjasi | -236,13 ming | 14,55% |
Har bir ulushga tushum | — | — |
EBITDA | -44,87 mln | 0,46% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | avg, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 277,18 mln | 109,41% |
Jami aktivlari | 352,64 mln | 62,48% |
Jami passivlari | 72,64 mln | 2,14% |
Umumiy kapital | 280,00 mln | — |
Tarqatilgan aksiyalar | 137,50 mln | — |
Narxi/balansdagi bahosi | 0,42 | — |
Aktivlardan daromad | -30,90% | — |
Kapitaldan daromad | -38,46% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | avg, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -44,86 mln | 9,80% |
Operatsiyalardan naqd pul | -35,94 mln | -23,25% |
Sarmoyadan naqd pul | -2,37 mln | -112,60% |
Moliyadan naqd pul | -1,07 mln | -28,16% |
Naqd pulning sof oʻzgarishi | -42,08 mln | -309,55% |
Boʻsh pul | -29,96 mln | -101,06% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
39
